LifeMD, Inc. — Director's Dealing 2023

Jul 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-01-27

Reporting Person: Benathen Marc David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-27	Common Stock	M	25000	—	Acquired	77554	Direct
2023-07-11	Common Stock	A	125000	—	Acquired	202554	Direct
2023-07-11	Common Stock	M	25000	—	Acquired	227554	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-11	Employee Stock Option (Right to Buy)	$21.2	D	200000	Disposed		Common Stock (200000)	Direct
2023-01-27	Restricted Stock	$	M	25000	Disposed		Common Stock (25000)	Direct
2023-07-11	Restricted Stock	$	M	25000	Disposed		Common Stock (25000)	Direct

Footnotes

F1: The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.

F2: Restricted stock converts into common stock on a one-for-one basis.

F3: Restricted stock vested on January 27, 2023.